Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
grade B 9.81 -4.48% -0.46
MNOV closed down 4.48 percent on Friday, January 18, 2019, on approximately normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MNOV trend table...

Date Alert Name Type % Chg
Jan 18 Bearish Engulfing Bearish 0.00%
Jan 18 Fell Below 200 DMA Bearish 0.00%
Jan 18 Stochastic Sell Signal Bearish 0.00%
Jan 18 Multiple of Ten Bearish Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Crossed Above 200 DMA Bullish -4.48%
Jan 17 Pocket Pivot Bullish Swing Setup -4.48%
Jan 17 Multiple of Ten Bullish Other -4.48%
Jan 17 Wide Bands Range Expansion -4.48%

Older signals for MNOV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Is MNOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.5
52 Week Low 6.87
Average Volume 81,396
200-Day Moving Average 10.0333
50-Day Moving Average 9.3574
20-Day Moving Average 8.8045
10-Day Moving Average 9.573
Average True Range 0.4799
ADX 24.89
+DI 34.6901
-DI 16.4834
Chandelier Exit (Long, 3 ATRs ) 8.9803
Chandelier Exit (Short, 3 ATRs ) 8.7397
Upper Bollinger Band 10.5002
Lower Bollinger Band 7.1088
Percent B (%b) 0.8
BandWidth 38.518939
MACD Line 0.2273
MACD Signal Line 0.0325
MACD Histogram 0.1948
Fundamentals Value
Market Cap 344.02 Million
Num Shares 35.1 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -33.83
Price-to-Sales 0.00
Price-to-Book 6.66
PEG Ratio -0.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.71
Resistance 3 (R3) 10.77 10.52 10.56
Resistance 2 (R2) 10.52 10.29 10.50 10.51
Resistance 1 (R1) 10.17 10.15 10.05 10.11 10.46
Pivot Point 9.92 9.92 9.86 9.90 9.92
Support 1 (S1) 9.57 9.69 9.45 9.51 9.16
Support 2 (S2) 9.32 9.55 9.30 9.11
Support 3 (S3) 8.97 9.32 9.06
Support 4 (S4) 8.91